×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Lin Shao-Lee

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SLRNACELYRIN, Inc.Lin Shao-LeeChief Executive OfficerApr 01, 2024Sale$6.639,96166,0241,577,374Apr 03, 2024, 06:18 PM
SLRNACELYRIN, Inc.Lin Shao-LeeChief Executive OfficerFeb 20, 2024Sale$7.6015,701119,4031,587,335Feb 22, 2024, 07:04 PM
SLRNACELYRIN, Inc.Lin Shao-LeeChief Executive OfficerJan 02, 2024Sale$7.4110,69179,1881,603,036Jan 04, 2024, 06:09 PM
SLRNACELYRIN, Inc.Lin Shao-LeeChief Executive OfficerMay 09, 2023Option Exercise$24.69337,1798,324,950770,034May 11, 2023, 08:50 PM
HZNPHorizon Therapeutics Public Ltd CoLin Shao-LeeEVP, Head of R&D and CSOJan 21, 2020Option Exercise$38.252,716103,887109,668Jan 23, 2020, 04:22 PM
HZNPHorizon Therapeutics Public Ltd CoLin Shao-LeeEVP, Head of R&D and CSOJan 04, 2020Option Exercise$36.108,113292,87958,359Jan 07, 2020, 06:21 PM
HZNPHorizon Therapeutics Public Ltd CoLin Shao-LeeEVP, Head of R&D and CSOJan 05, 2020Option Exercise$36.1038,1001,375,410106,255Jan 07, 2020, 06:21 PM
HZNPHorizon Pharma plcLin Shao-LeeEVP, Head of R&D and CSOFeb 20, 2019Option Exercise$21.5415,795340,22447,531Feb 22, 2019, 05:23 PM
HZNPHorizon Pharma plcLin Shao-LeeEVP, Head of R&D and CSOJan 04, 2019Option Exercise$20.398,242168,0549,649Jan 08, 2019, 08:40 PM
HZNPHorizon Pharma plcLin Shao-LeeEVP, Head of R&D and CSOJan 05, 2019Option Exercise$20.3914,337292,33127,674Jan 08, 2019, 08:40 PM